The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012
- PMID: 25367997
- PMCID: PMC4545491
- DOI: 10.1377/hlthaff.2014.0833
The 340B discount program: outpatient prescription dispensing patterns through contract pharmacies in 2012
Abstract
Section 340B of the Public Health Service Act provides qualified organizations serving vulnerable populations with deep discounts for some outpatient medications. A 2010 regulatory change widely expanded the 340B program's reach, allowing these organizations to contract with retail pharmacies to dispense medications for eligible patients. Little is known about which medications are dispensed by contract pharmacies under the expanded program. We provide the first comparison of 340B prescriptions and all prescriptions dispensed in contract pharmacies. We used 2012 data from Walgreens, the national leader in 340B contract pharmacies. Medications used to treat chronic conditions such as diabetes, high cholesterol levels, asthma, and depression accounted for an overwhelming majority of all prescriptions dispensed at Walgreens as part of the 340B program. A higher percentage of antiretrovirals used to treat HIV/AIDS were dispensed through 340B prescriptions than through all prescriptions dispensed at Walgreens. The majority of 340B prescriptions dispensed at Walgreens originated at tuberculosis clinics, consolidated health centers, disproportionate-share hospitals, and Ryan White clinics. Our results suggest that 340B contract pharmacies dispense medications used to treat Americans' chronic disease burden and disproportionately dispense medications used by key vulnerable populations targeted by the program.
Keywords: Access To Care; Pharmaceuticals; Safety-Net Systems; Special Populations.
Project HOPE—The People-to-People Health Foundation, Inc.
Similar articles
-
The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.Health Aff (Millwood). 2014 Oct;33(10):1786-92. doi: 10.1377/hlthaff.2014.0540. Health Aff (Millwood). 2014. PMID: 25288423 Free PMC article.
-
Comprehensive Legislative Reform to Protect the Integrity of the 340B Drug Discount Program.Food Drug Law J. 2015;70(4):481-99, i. Food Drug Law J. 2015. PMID: 26827389
-
Revenues and Profits From Medicare Patients in Hospitals Participating in the 340B Drug Discount Program, 2013-2016.JAMA Netw Open. 2019 Oct 2;2(10):e1914141. doi: 10.1001/jamanetworkopen.2019.14141. JAMA Netw Open. 2019. PMID: 31664442 Free PMC article.
-
Examining the Benefits of the 340b Drug Discount Program.Health Care Manag (Frederick). 2018 Jul/Sep;37(3):225-231. doi: 10.1097/HCM.0000000000000220. Health Care Manag (Frederick). 2018. PMID: 29901471 Review.
-
The 340b Program, Contract Pharmacies, Hospitals, and Patients: An Evolving Relationship Impacting Health Care Delivery.Health Care Manag (Frederick). 2019 Oct/Dec;38(4):311-321. doi: 10.1097/HCM.0000000000000279. Health Care Manag (Frederick). 2019. PMID: 31663869
Cited by
-
Interpreting 340B contract pharmacy growth: who really benefits?Health Aff Sch. 2023 Dec 9;2(1):qxad076. doi: 10.1093/haschl/qxad076. eCollection 2024 Jan. Health Aff Sch. 2023. PMID: 38756400 Free PMC article. No abstract available.
-
Assessment of US Pharmacies Contracted With Health Care Institutions Under the 340B Drug Pricing Program by Neighborhood Socioeconomic Characteristics.JAMA Health Forum. 2022 Jun 17;3(6):e221435. doi: 10.1001/jamahealthforum.2022.1435. eCollection 2022 Jun. JAMA Health Forum. 2022. PMID: 35977245 Free PMC article.
-
Opportunities and Challenges of Generic Pre-Exposure Prophylaxis Drugs for HIV.J Law Med Ethics. 2022;50(S1):32-39. doi: 10.1017/jme.2022.33. J Law Med Ethics. 2022. PMID: 35902088 Free PMC article.
-
Outcomes of the 340B Drug Pricing Program: A Scoping Review.JAMA Health Forum. 2023 Nov 3;4(11):e233716. doi: 10.1001/jamahealthforum.2023.3716. JAMA Health Forum. 2023. PMID: 37991784 Free PMC article.
-
Consequences of the 340B Drug Pricing Program.N Engl J Med. 2018 Feb 8;378(6):539-548. doi: 10.1056/NEJMsa1706475. Epub 2018 Jan 24. N Engl J Med. 2018. PMID: 29365282 Free PMC article.
References
-
- Health Resources and Services Administration. 340B Drug Pricing Program: eligibility and registration [Internet] Rockville (MD): HRSA; [cited 2014 Oct 2]. Available from: http://www.hrsa.gov/opa/eligibilityandregistration/index.html.
-
- Health Resources and Services Administration. Exclusion of orphan drugs for certain covered entities under 340B program. [cited 2014 Sep 25];Federal Register [serial on the Internet] 2013 Jul 23; Available from: http://www.gpo.gov/fdsys/pkg/FR-2013-07-23/pdf/2013-17547.pdf. - PubMed
-
- Health Resources and Services Administration. Alternative Methods Demonstration Projects [Internet] Rockville (MD): HRSA; [cited 2014 Sep 25]. Available from: http://www.hrsa.gov/opa/implementation/alternativemethods/index.html.
-
- Health Resources and Services Administration. Notice regarding 340B Drug Pricing Program—contract pharmacy services. [cited 2014 Oct 2];Federal Register [serial on the Internet] 2010 Mar 5; Available from: http://www.gpo.gov/fdsys/pkg/FR-2010-03-05/pdf/2010-4755.pdf.
-
- American Society of Clinical Oncology. Policy statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology. J Oncol Pract. 2014;10(4):259–263. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources